TSC2 and breast cancer: In patients with breast cancer in TCGA, lower (vs. higher) expression of phospho-tuberin T1462 and phospho-PRAS40 T246 in luminal breast cancer is associated with better breast cancer-specific survival (Supplemental Figure S5).